Wiederhold NP - Search Results

1

Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity.

Wiederhold NP, Kontoyiannis DP, Chi J, Prince RA, Tam VH, Lewis RE. Wiederhold NP, et al. J Infect Dis. 2004 Oct 15;190(8):1464-71. doi: 10.1086/424465. Epub 2004 Sep 10. J Infect Dis. 2004. PMID: 15378439

2

The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy.

Wiederhold NP, Lewis RE. Wiederhold NP, et al. Expert Opin Investig Drugs. 2003 Aug;12(8):1313-33. doi: 10.1517/13543784.12.8.1313. Expert Opin Investig Drugs. 2003. PMID: 12882619 Review.

3

The solubility ceiling: a rationale for continuous infusion amphotericin B therapy?

Lewis RE, Wiederhold NP. Lewis RE, et al. Among authors: wiederhold np. Clin Infect Dis. 2003 Sep 15;37(6):871-2. doi: 10.1086/377279. Clin Infect Dis. 2003. PMID: 12955666 No abstract available.

4

Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.

Liu W, Lionakis MS, Lewis RE, Wiederhold N, May GS, Kontoyiannis DP. Liu W, et al. Antimicrob Agents Chemother. 2003 Nov;47(11):3592-7. doi: 10.1128/AAC.47.11.3592-3597.2003. Antimicrob Agents Chemother. 2003. PMID: 14576123 Free PMC article.

5

Invasive aspergillosis in patients with hematologic malignancies.

Wiederhold NP, Lewis RE, Kontoyiannis DP. Wiederhold NP, et al. Pharmacotherapy. 2003 Dec;23(12):1592-610. doi: 10.1592/phco.23.15.1592.31965. Pharmacotherapy. 2003. PMID: 14695039 Review.

6

Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.

Barker KS, Crisp S, Wiederhold N, Lewis RE, Bareither B, Eckstein J, Barbuch R, Bard M, Rogers PD. Barker KS, et al. J Antimicrob Chemother. 2004 Aug;54(2):376-85. doi: 10.1093/jac/dkh336. Epub 2004 Jun 16. J Antimicrob Chemother. 2004. PMID: 15201233

7

Detection of gliotoxin in experimental and human aspergillosis.

Lewis RE, Wiederhold NP, Chi J, Han XY, Komanduri KV, Kontoyiannis DP, Prince RA. Lewis RE, et al. Among authors: wiederhold np. Infect Immun. 2005 Jan;73(1):635-7. doi: 10.1128/IAI.73.1.635-637.2005. Infect Immun. 2005. PMID: 15618207 Free PMC article.

8

In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.

Lewis RE, Wiederhold NP, Klepser ME. Lewis RE, et al. Among authors: wiederhold np. Antimicrob Agents Chemother. 2005 Mar;49(3):945-51. doi: 10.1128/AAC.49.3.945-951.2005. Antimicrob Agents Chemother. 2005. PMID: 15728887 Free PMC article.

9

Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence.

Lionakis MS, Lewis RE, May GS, Wiederhold NP, Albert ND, Halder G, Kontoyiannis DP. Lionakis MS, et al. Among authors: wiederhold np. J Infect Dis. 2005 Apr 1;191(7):1188-95. doi: 10.1086/428587. Epub 2005 Feb 28. J Infect Dis. 2005. PMID: 15747256

10

Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.

Wiederhold NP, Coyle EA, Raad II, Prince RA, Lewis RE. Wiederhold NP, et al. J Antimicrob Chemother. 2005 May;55(5):792-5. doi: 10.1093/jac/dki106. Epub 2005 Apr 6. J Antimicrob Chemother. 2005. PMID: 15814598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters